Acadia Pharmaceuticals to Present at Upcoming Investor Conferences
01 September 2022 - 11:03PM
Business Wire
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that
it will participate at the following upcoming investor
conferences:
Citi’s 17th Annual BioPharma Conference Fireside Chat:
Thursday, September 8, 2022 at 1:00 p.m. Eastern Time in Boston,
MA
Morgan Stanley 20th Annual Global Healthcare Conference
Fireside Chat: Tuesday, September 13, 2022 at 11:10 a.m. Eastern
Time in New York, NY
Cowen 2nd Annual Novel Mechanisms in Neuropsychiatry Virtual
Summit Fireside Chat: Monday, September 19, 2022 at 2:10 p.m.
Eastern Time
Live webcasts of the presentations will be accessible on the
company’s website, www.acadia.com, under the investors section and
an archived recording will be available on the website for
approximately one month following each presentation.
About Acadia Pharmaceuticals Acadia is advancing breakthroughs
in neuroscience to elevate life. For more than 25 years we have
been working at the forefront of healthcare to bring vital
solutions to people who need them most. We developed and
commercialized the first and only approved therapy for
hallucinations and delusions associated with Parkinson’s disease
psychosis. Our clinical-stage development efforts are focused on
treating the negative symptoms of schizophrenia, Rett syndrome and
neuropsychiatric symptoms in central nervous system disorders. For
more information, visit us at www.acadia.com and follow us on
LinkedIn and Twitter.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220901005268/en/
Media Contact: Acadia Pharmaceuticals Inc. Deb Kazenelson (818)
395-3043 media@acadia-pharm.com Investor Contact: Acadia
Pharmaceuticals Inc. Mark Johnson, CFA (858) 261-2771
ir@acadia-pharm.com
Acadia Pharmaceuticals (NASDAQ:ACAD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Acadia Pharmaceuticals (NASDAQ:ACAD)
Historical Stock Chart
From Apr 2023 to Apr 2024